학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 3,322건 | 목록 1~20
Conference
2025 European Conference on Optical Communications (ECOC) Optical Communications (ECOC), 2025 European Conference on. :1-4 Sep, 2025
Conference
2017 13th Conference on Ph.D. Research in Microelectronics and Electronics (PRIME) Ph.D. Research in Microelectronics and Electronics (PRIME), 2017 13th Conference on. :41-44 Jun, 2017
Conference
2020 European Conference on Optical Communications (ECOC) Optical Communications (ECOC), 2020 European Conference on. :1-4 Dec, 2020
Academic Journal
Arnould B; Laboratoire de Chémo-Biologie Synthétique et Thérapeutique (CBST) UMR 7199, équipe Ingénierie Canaux Ioniques, Centre National de la Recherche Scientifique, Université de Strasbourg, Faculté de Pharmacie, Illkirch, France.; Martz A; Laboratoire de Chémo-Biologie Synthétique et Thérapeutique (CBST) UMR 7199, équipe Ingénierie Canaux Ioniques, Centre National de la Recherche Scientifique, Université de Strasbourg, Faculté de Pharmacie, Illkirch, France.; Belzanne P; Interdisciplinary Institute for Neuroscience, CNRS, Université de Bordeaux, Bordeaux, France.; Peralta FA; Laboratoire de Chémo-Biologie Synthétique et Thérapeutique (CBST) UMR 7199, équipe Ingénierie Canaux Ioniques, Centre National de la Recherche Scientifique, Université de Strasbourg, Faculté de Pharmacie, Illkirch, France.; University of Strasbourg Institute for Advanced Studies (USIAS), Strasbourg, France.; Cevoli F; Laboratoire de Chémo-Biologie Synthétique et Thérapeutique (CBST) UMR 7199, équipe Ingénierie Canaux Ioniques, Centre National de la Recherche Scientifique, Université de Strasbourg, Faculté de Pharmacie, Illkirch, France.; Hovhannisyan V; Centre National de la Recherche Scientifique-Unité Propre de Recherche (CNRS-UPR) 3212, Institut des Neurosciences Cellulaires et Intégratives, Strasbourg, France.; Goumon Y; Centre National de la Recherche Scientifique-Unité Propre de Recherche (CNRS-UPR) 3212, Institut des Neurosciences Cellulaires et Intégratives, Strasbourg, France.; Hosy E; Interdisciplinary Institute for Neuroscience, CNRS, Université de Bordeaux, Bordeaux, France.; Specht A; Laboratoire de Chémo-Biologie Synthétique et Thérapeutique (CBST) UMR 7199, équipe NanoParticules Intelligentes, Centre National de la Recherche Scientifique, Université de Strasbourg, Strasbourg, France.; Grutter T; Laboratoire de Chémo-Biologie Synthétique et Thérapeutique (CBST) UMR 7199, équipe Ingénierie Canaux Ioniques, Centre National de la Recherche Scientifique, Université de Strasbourg, Faculté de Pharmacie, Illkirch, France.; University of Strasbourg Institute for Advanced Studies (USIAS), Strasbourg, France.
Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Academic Journal
Lanar S; Insights, Evidence, and Value, ICON plc, Lyon, France.; Kefsi A; Early Development Oncology, Sanofi Global R&D, Vitry, France.; Armaou M; Insights, Evidence, and Value, ICON plc, Reading, UK.; Jones-Lemmons F; Insights, Evidence, and Value, ICON plc, Raleigh, North Carolina, USA.; de La Cruz M; Insights, Evidence, and Value, ICON plc, Raleigh, North Carolina, USA.; Lipman K; Insights, Evidence, and Value, ICON plc, Raleigh, North Carolina, USA.; Arnould B; Patient Informed Development & Health Value, Translation, Sanofi Global R&D, Lyon, France.; Gousset C; Patient Informed Development & Health Value, Translation, Sanofi Global R&D, Gentilly, France.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101629607 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2045-0923 (Print) Linking ISSN: 20450923 NLM ISO Abbreviation: Hepat Oncol Subsets: PubMed not MEDLINE
Academic Journal
107 Nw. U. L. Rev. 915 (2012-2013) / Northwestern University Law Review, Vol. 107, Issue 2 (Winter 2013), pp. 915-918
Academic Journal
64 Fla. L. Rev. 1485 (2012) / Florida Law Review, Vol. 64, Issue 6 (December 2012), pp. 1485-1538
Conference
2018 IEEE 4th Middle East Conference on Biomedical Engineering (MECBME) Biomedical Engineering (MECBME), 2018 IEEE 4th Middle East Conference on. :159-164 Mar, 2018
Reference
Oxford Art Online, 2003
Academic Journal
Wells ET; IQVIA, Strategy and Life Sciences Consulting, Durham, NC, USA. edward.wells@iqvia.com.; Lucats L; Sanofi, Patient-Informed Development and Health Value Translation, Research and Development, Gentilly, France.; Abbadessa G; Former Employee of Sanofi, Cambridge, MA, USA.; Turnbull J; IQVIA Strategy and Life Sciences, Consulting, New York, USA.; Talavera JR; Sanofi Patient Safety and Pharmacovigilance, Research and Development, Cambridge, MA, USA.; Van Tomme SR; Sanofi Patient-Informed Development and Health Value Translation, Research and Development, Amsterdam, The Netherlands.; Cordero P; Sanofi, Patient-Informed Development and Health Value Translation, Research and Development, Reading, UK.; Arnould B; Sanofi, Patient-Informed Development and Health Value Translation, Research and Development, Lyon, France.; Reaney M; IQVIA Real World Solutions, Consulting, Reading, UK.; Coulouvrat C; Sanofi, Patient-Informed Development and Health Value Translation, Research and Development, Gentilly, France.
Publisher: Adis Country of Publication: New Zealand NLM ID: 101677510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2366-1089 (Electronic) Linking ISSN: 23661089 NLM ISO Abbreviation: Oncol Ther Subsets: PubMed not MEDLINE
Conference
2016 28th International Symposium on Power Semiconductor Devices and ICs (ISPSD) Power Semiconductor Devices and ICs (ISPSD), 2016 28th International Symposium on. :443-446 Jun, 2016
Academic Journal
Maalouf G; Sorbonne Universités AP-HP, Groupe Hospitalier Pitié-Salpêtrière , Département de Médecine Interne et immunologie Clinique, F-75013, Paris , France , Centre National de Références Maladies Autoimmunes Systémiques Rares, Centre National de Références Maladies Autoinflammatoires et Amylose Inflammatoire ( CEREMAIA) ; Inflammation-Immunopathology-Biotherapy Department (DMU 3iD) ; CIC Biotherapy ; INSERM 959, Groupe Hospitalier Pitié Salpetriere, AP-HP, Paris, France.; Arnould B; Department of Internal Medicine, CHU Rouen, Rouen, France.; Espitia O; Department of Vascular Medicine, CHU Nantes, Nantes, France.; Deboysson H; Department of Internal Medicine, CHU Caen, Caen, France.; Samson M; Internal medecine and systemic disease unit, CHU Dijon, Dijon, Burgundy, France.; Hot A; Department of Internal Medicine, Hopital Edouard-Herriot, Lyon, France.; Liozon E; Department of Internal Medicine, CHU Limoges, Limoges, France.; Parreau S; Department of Internal Medicine, Hopital Dupuytren, Limoges, France.; Lavigne C; Médecine interne et polyvalente, CH du Haut-Anjou, Chateau-Gontier ; Médecine interne, CHU d'Angers.; Lacombe V; Médecine interne et polyvalente, CH du Haut-Anjou, Chateau-Gontier ; Médecine interne, CHU d'Angers.; Alexandra JF; Department de Médecine interne-Immunologie clinique, CHU d'Angers, Angers, France, Centre National de Référence Maladies Autoimmunes Systémiques Rares CeRAINOM-Angers.; Thibault T; Internal medecine and systemic disease unit, CHU Dijon, Dijon, Burgundy, France.; Chiche L; Department of Vascular Surgery, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.; Gaudric J; Department of Vascular Surgery, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.; Redheuil A; Department of Vascular and Interventional radiology, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.; Vieira M; Sorbonne Universités AP-HP, Groupe Hospitalier Pitié-Salpêtrière , Département de Médecine Interne et immunologie Clinique, F-75013, Paris , France , Centre National de Références Maladies Autoimmunes Systémiques Rares, Centre National de Références Maladies Autoinflammatoires et Amylose Inflammatoire ( CEREMAIA) ; Inflammation-Immunopathology-Biotherapy Department (DMU 3iD) ; CIC Biotherapy ; INSERM 959, Groupe Hospitalier Pitié Salpetriere, AP-HP, Paris, France.; Groh M; Department of Internal Medicine, Hôpital Foch, Suresnes, France.; Durel CA; Department of Internal Medicine, Hopital Edouard-Herriot, Lyon, France.; Chazal T; Department of Internal Medicine, Hôpital Fondation Adolphe-de-Rothschild, Paris, France.; Comarmond C; Department of Internal Medicine, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France.; Magy-Bertrand N; Department of Internal Medicine, CHRU Jean-Minjoz, Besançon, France.; Vinzio S; Department of Internal Medicine, Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France.; Martzolff L; Department of Internal Medicine, Groupe Hospitalier Région Mulhouse et Sud Alsace, Hôpital Emile-Muller, Mulhouse, France.; Lozac'h P; Department of Internal Medicine, CH Le Mans, Le Mans, France.; Outh R; Department of Internal Medicine, CHU Grabiel-Montpied, Clermont-Ferrand, France.; Clément J; Department of Internal Medicine, CH de Blois, Blois, France.; Duffau P; Department of Internal Medicine, CHU de Bordeaux, Bordeaux, France.; Dumont A; Department of Internal Medicine, CHU Caen, Caen, France.; Humbert S; Department of Internal medicine, Centre Hospitalier Louis Pasteur, Dole, France.; Guillaud C; Department of Internal Medicine, Hôpital Henri-Mondor, Créteil, France.; Dellal A; Department of Rheumatology, GHJ Le Raincy-Montfermeil, Montfermeil, France.; Pugnet G; Department of Internal Medicine and Clinical Immunology, CHU Rangueil, Toulouse, France.; Devauchelle-Pensec V; Department of Rheumatology, Hôpital de La Cavale-Blanche, Brest, France.; Cacoub P; Sorbonne Universités AP-HP, Groupe Hospitalier Pitié-Salpêtrière , Département de Médecine Interne et immunologie Clinique, F-75013, Paris , France , Centre National de Références Maladies Autoimmunes Systémiques Rares, Centre National de Références Maladies Autoinflammatoires et Amylose Inflammatoire ( CEREMAIA) ; Inflammation-Immunopathology-Biotherapy Department (DMU 3iD) ; CIC Biotherapy ; INSERM 959, Groupe Hospitalier Pitié Salpetriere, AP-HP, Paris, France.; Biard L; Department of Biostatistics, Hopital Saint Louis, Paris.; Saadoun D; Sorbonne Universités AP-HP, Groupe Hospitalier Pitié-Salpêtrière , Département de Médecine Interne et immunologie Clinique, F-75013, Paris , France , Centre National de Références Maladies Autoimmunes Systémiques Rares, Centre National de Références Maladies Autoinflammatoires et Amylose Inflammatoire ( CEREMAIA) ; Inflammation-Immunopathology-Biotherapy Department (DMU 3iD) ; CIC Biotherapy ; INSERM 959, Groupe Hospitalier Pitié Salpetriere, AP-HP, Paris, France.
Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Arnould B
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어